Rare diseases
Investigational molecules
Locations
Back to Bulgaria12 clinical trials in Targovishte, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments
BulgariaA study to evaluate the effectiveness and safety of NBI-1117570 in adults with schizophrenia who require hospital treatment.
BulgariaStudy of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants
BulgariaStudy on ITI-1284 for Patients with Generalized Anxiety Disorder Not Responding to Current Treatment
BulgariaComparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery
BulgariaStudy on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms
BulgariaStudy on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients
BulgariaStudy of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms
BulgariaBulgariaBulgariaStudy on the Safety and Tolerability of Cariprazine for Treating Schizophrenia in Adolescents Aged 13-17
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on schizophrenia treatment, particularly in adolescent populations, alongside studies examining cognitive impairment associated with the condition.
Multiple trials evaluating new therapeutic approaches and adjunctive treatments for better symptom management.
Innovative studies addressing Major Depressive Disorder and Generalized Anxiety Disorder, testing novel therapeutic compounds for improved treatment outcomes.
Focus on developing adjunctive therapies and evaluating long-term safety profiles of new medications.
Groundbreaking research in Type 2 Diabetes management, including specialized studies for younger patients and optimization of treatment combinations.
Innovative approaches to glycemic control in both adult and adolescent populations.
Advanced research in atherosclerotic cardiovascular disease prevention, evaluating new therapeutic approaches for high-risk patients.
Focus on preventing major adverse cardiovascular events through innovative treatments.
Specialized research examining treatments for Psoriatic Arthritis, with particular attention to axial disease manifestations.
Evaluation of targeted therapies for improved patient outcomes in inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
